{"log_id": 7103698236688005353, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 3e-06, "average": 0.998701, "min": 0.993729}, "location": {"width": 836, "top": 141, "height": 33, "left": 180}, "words": "去铁酮可导致嗜中性白细胞减少症,包括粒细胞缺乏症。建议每周监测患者的白细胞计数"}, {"probability": {"variance": 0, "average": 0.923036, "min": 0.923036}, "location": {"width": 19, "top": 139, "height": 24, "left": 1175}, "words": "手"}, {"probability": {"variance": 4.9e-05, "average": 0.997701, "min": 0.958435}, "location": {"width": 856, "top": 173, "height": 32, "left": 179}, "words": "这一方法在临床试验中曾有效地查出嗜中性白细胞减少症和粒细胞缺乏症的病例。一旦治疗"}, {"probability": {"variance": 2e-06, "average": 0.998989, "min": 0.991342}, "location": {"width": 857, "top": 203, "height": 35, "left": 180}, "words": "中止,嗜中性白细胞减少症及粒细胞缺乏症可以恢复。如果患者发生感染,应中断服用去铁"}, {"probability": {"variance": 0.000137, "average": 0.996768, "min": 0.931799}, "location": {"width": 850, "top": 236, "height": 34, "left": 178}, "words": "酮并增加监测白细胞数的次数。患者应立即向医生报告如何与感染相关的症状,例如:发热"}, {"probability": {"variance": 0, "average": 0.999645, "min": 0.997711}, "location": {"width": 218, "top": 271, "height": 25, "left": 179}, "words": "咽喉痛以及流感样症状"}, {"probability": {"variance": 0.0001, "average": 0.997609, "min": 0.935554}, "location": {"width": 858, "top": 332, "height": 38, "left": 178}, "words": "对嗜中性白细胞减少的病例建议按下列方案处理,这种处理方案应置于每一病人在开始应于"}, {"probability": {"variance": 6e-06, "average": 0.998988, "min": 0.984657}, "location": {"width": 858, "top": 365, "height": 36, "left": 178}, "words": "去铁酮治疗之前。如果患者嗜中性白细胞偏低,不应给予去铁酮治疗。如果嗜中性白细胞计"}, {"probability": {"variance": 0.015139, "average": 0.966679, "min": 0.39961}, "location": {"width": 761, "top": 399, "height": 33, "left": 176}, "words": "数(ANC)低于1.5X10°/,则患粒细胞缺乏症和嗜中性白细胞减少症的危险增加"}, {"probability": {"variance": 8e-06, "average": 0.998548, "min": 0.984244}, "location": {"width": 860, "top": 465, "height": 34, "left": 176}, "words": "出现嗜中性白细胞减少的情况,应立即指导患者中断服用去铁酮及其他所有可导致嗜中性白"}, {"probability": {"variance": 1e-06, "average": 0.999344, "min": 0.993424}, "location": {"width": 861, "top": 496, "height": 37, "left": 176}, "words": "细胞减少的药物。应建议患者限制与其他人的接触以减少潜在的感染危险。立即进行全血细"}, {"probability": {"variance": 1e-06, "average": 0.999301, "min": 0.997439}, "location": {"width": 861, "top": 530, "height": 36, "left": 175}, "words": "胞计数,校正的白细胞计数,嗜中性白细胞计数,及血小板计数用于病例诊断,并且每日重"}, {"probability": {"variance": 8e-06, "average": 0.998462, "min": 0.987703}, "location": {"width": 856, "top": 562, "height": 36, "left": 176}, "words": "复上述检查项目。待嗜中性白细胞数复原后,还要连续三周,每周进行全血细胞计数(CBC)"}, {"probability": {"variance": 0.000658, "average": 0.994197, "min": 0.831291}, "location": {"width": 860, "top": 596, "height": 35, "left": 176}, "words": "校正的白细胞计数(WBC),嗜中性白细胞和血小板计数,以确保患者完全恢复。任何嗜中性"}, {"probability": {"variance": 3e-06, "average": 0.999113, "min": 0.990994}, "location": {"width": 827, "top": 627, "height": 36, "left": 175}, "words": "白细胞减少伴发的感染迹象,应进行细菌培养和诊断以保证可以进行适当的抗生素治疗"}, {"probability": {"variance": 4.9e-05, "average": 0.997606, "min": 0.955233}, "location": {"width": 859, "top": 694, "height": 32, "left": 175}, "words": "出现严重的嗜中性白细胞减少或粒细胞缺乏的情况,一旦确诊,就应遵循上述准则,并给予"}, {"probability": {"variance": 6e-06, "average": 0.998813, "min": 0.986728}, "location": {"width": 928, "top": 718, "height": 46, "left": 172}, "words": "恰当的治疗,例如粒细胞生长因子;每日给药,直至嗜中性白细胞计数恢复正常进行隔离"}, {"probability": {"variance": 1e-06, "average": 0.99928, "min": 0.995436}, "location": {"width": 373, "top": 759, "height": 26, "left": 173}, "words": "保护,如果临床指征允许,患者应住院"}, {"probability": {"variance": 1.6e-05, "average": 0.997969, "min": 0.983533}, "location": {"width": 857, "top": 817, "height": 43, "left": 176}, "words": "上述症状恢复后,再用去铁酮的资料是有限的。因此不建议在嗜中性白细胞减少时再进行去"}, {"probability": {"variance": 1e-06, "average": 0.999262, "min": 0.994628}, "location": {"width": 504, "top": 855, "height": 28, "left": 172}, "words": "铁酮的治疗,粒细胞缺乏时,再用去铁酮治疗是禁忌"}, {"probability": {"variance": 5e-05, "average": 0.996737, "min": 0.974506}, "location": {"width": 242, "top": 919, "height": 29, "left": 171}, "words": "血清铁蛋白浓度/血浆Zn"}, {"probability": {"variance": 2e-06, "average": 0.999169, "min": 0.992273}, "location": {"width": 852, "top": 950, "height": 37, "left": 171}, "words": "建议每月测定血清铁蛋白浓度,至少每两个月测定一次,用以评估螯合剂治疗的长期疗效"}, {"probability": {"variance": 0.013899, "average": 0.966705, "min": 0.41551}, "location": {"width": 864, "top": 983, "height": 35, "left": 169}, "words": "控制体内铁负荷。如果血清铁蛋白低于500g/1,应停止服用去铁酮。血浆Zn2含量的测定"}, {"probability": {"variance": 3e-06, "average": 0.998631, "min": 0.993466}, "location": {"width": 287, "top": 1016, "height": 27, "left": 172}, "words": "可以作为血锌缺乏时补充监测"}, {"probability": {"variance": 0.002127, "average": 0.980163, "min": 0.824407}, "location": {"width": 286, "top": 1081, "height": 28, "left": 167}, "words": "HIV阳性或其它免疫缺陷患者"}, {"probability": {"variance": 0.002335, "average": 0.983585, "min": 0.795601}, "location": {"width": 862, "top": 1112, "height": 35, "left": 170}, "words": "尚无HIV阳性或其它免疫缺陷患者使用去铁酮的资料。因为去铁酮与白细胞减少和粒细胞缺"}, {"probability": {"variance": 4e-06, "average": 0.998643, "min": 0.990771}, "location": {"width": 829, "top": 1146, "height": 34, "left": 170}, "words": "乏相关,所以除非应于去铁酮的益处大于潜在的危害,免疫缺陷患者应避免使用去铁酮"}, {"probability": {"variance": 5e-06, "average": 0.998982, "min": 0.991722}, "location": {"width": 243, "top": 1213, "height": 26, "left": 169}, "words": "肝肾功能不良和肝纤维化"}, {"probability": {"variance": 5e-06, "average": 0.998988, "min": 0.985465}, "location": {"width": 861, "top": 1244, "height": 36, "left": 170}, "words": "目前尚无在肝肾功能不良患者中使用的资料。由于去铁酮在肾脏清除,可能会增加肾功能不"}, {"probability": {"variance": 5e-06, "average": 0.999052, "min": 0.98576}, "location": {"width": 862, "top": 1279, "height": 34, "left": 169}, "words": "良患者并发症的危险性。同样,由于去铁酮在肝脏代谢,所以肝功能不良患者应慎用。目前"}, {"probability": {"variance": 4e-06, "average": 0.998815, "min": 0.991385}, "location": {"width": 852, "top": 1310, "height": 37, "left": 168}, "words": "尚不能确定去铁酮是否会加重肝纤维化。在地中海贫血患者中,肝纤维化与丙型肝炎相关"}, {"probability": {"variance": 1e-06, "average": 0.9993, "min": 0.99552}, "location": {"width": 866, "top": 1345, "height": 35, "left": 165}, "words": "对伴有丙肝的患者使用本品时,应确保药物使用是有益于治疗时方可使用。对这些患者建议"}, {"probability": {"variance": 9e-06, "average": 0.998621, "min": 0.987608}, "location": {"width": 864, "top": 1378, "height": 35, "left": 167}, "words": "进行肝脏组织学监测。在上述患者群应用去铁酮治疗期间,需要检查肝与肾功能,若ALT"}, {"probability": {"variance": 0, "average": 0.999684, "min": 0.998862}, "location": {"width": 264, "top": 1411, "height": 27, "left": 166}, "words": "持续升高,应考虑中断治疗"}, {"probability": {"variance": 0, "average": 0.999853, "min": 0.999782}, "location": {"width": 70, "top": 1479, "height": 26, "left": 166}, "words": "心功能"}, {"probability": {"variance": 2e-06, "average": 0.99859, "min": 0.994488}, "location": {"width": 373, "top": 1508, "height": 29, "left": 166}, "words": "尚无足够的去铁酮对心功能的影响资料"}], "language": 3}